» Articles » PMID: 2215081

Brain and Cerebrospinal Fluid Uptake of Zidovudine (AZT) in Rats After Intravenous Injection

Overview
Journal Life Sci
Publisher Elsevier
Date 1990 Jan 1
PMID 2215081
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Uptake kinetics of zidovudine into cerebrospinal fluid (CSF) and brain tissue were determined in adult Sprague Dawley male rats after single intravenous injection of 6.7 mg/kg (25 mumol/kg). The drug kinetics in plasma followed biexponential disposition with an initial distribution half-life of approximately 11 minutes and an elimination half-life of 40 minutes. Over the plasma concentration range of 0.2 to 10 micrograms/ml, the cerebrospinal fluid to plasma ratio averaged 14.8 +/- 1.9% whereas the mean brain tissue to plasma ratio was 8.2 +/- 1.2% (uncorrected) or 2.3 +/- 1.8% (corrected) for the brain vascular space contribution. Simultaneous nonlinear regression analysis of brain, CSF and plasma concentration data indicate that the overall rate constant for efflux of drug from brain is approximately 75-fold higher and from CSF is 8-fold higher than the respective rate constants for influx. Thus, the ratio of the efflux to influx appears to be the predominant factor in determining the net accumulation of drug into CSF and brain parenchymal tissue.

Citing Articles

Bile duct ligation enhances AZT CNS toxicity partly by impairing the expression and function of BCRP in rat brain.

Qin Y, Xu P, Wu T, Qian C, Fan Y, Gen D Acta Pharmacol Sin. 2019; 41(2):181-191.

PMID: 31142800 PMC: 7470810. DOI: 10.1038/s41401-019-0242-8.


Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals.

Nwogu J, Ma Q, Babalola C, Adedeji W, Morse G, Taiwo B AIDS Res Treat. 2016; 2016:2587094.

PMID: 27777797 PMC: 5061948. DOI: 10.1155/2016/2587094.


CSF penetration by antiretroviral drugs.

Eisfeld C, Reichelt D, Evers S, Husstedt I CNS Drugs. 2012; 27(1):31-55.

PMID: 23160938 DOI: 10.1007/s40263-012-0018-x.


Multifunctional peptide-PEG intercalating conjugates: programmatic of gene delivery to the blood-brain barrier.

Zhang H, Gerson T, Varney M, Singh R, Vinogradov S Pharm Res. 2010; 27(12):2528-43.

PMID: 20824308 PMC: 2998179. DOI: 10.1007/s11095-010-0256-x.


Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.

Frick L, St John L, Taylor L, Painter G, Furman P, Liotta D Antimicrob Agents Chemother. 1993; 37(11):2285-92.

PMID: 8285607 PMC: 192380. DOI: 10.1128/AAC.37.11.2285.